IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 140 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $18,852,971 | +22.6% | 1,521,628 | +2.6% | 0.01% | +25.0% |
Q3 2022 | $15,371,899 | -7.3% | 1,483,774 | +3.2% | 0.00% | 0.0% |
Q2 2022 | $16,577,073 | -56.8% | 1,437,734 | -52.9% | 0.00% | -50.0% |
Q1 2022 | $38,390,650 | +9.2% | 3,051,721 | +1.2% | 0.01% | +14.3% |
Q4 2021 | $35,170,000 | +51.7% | 3,016,328 | +69.9% | 0.01% | +40.0% |
Q3 2021 | $23,187,000 | +1.1% | 1,775,428 | -0.4% | 0.01% | 0.0% |
Q2 2021 | $22,934,000 | +13.5% | 1,781,953 | -1.4% | 0.01% | 0.0% |
Q1 2021 | $20,209,000 | -13.6% | 1,807,569 | -11.9% | 0.01% | 0.0% |
Q4 2020 | $23,377,000 | +26.6% | 2,052,390 | 0.0% | 0.01% | 0.0% |
Q3 2020 | $18,461,000 | -27.6% | 2,052,390 | -17.0% | 0.01% | -28.6% |
Q2 2020 | $25,511,000 | +0.5% | 2,471,979 | -1.7% | 0.01% | -22.2% |
Q1 2020 | $25,385,000 | -26.0% | 2,515,848 | -2.4% | 0.01% | -10.0% |
Q4 2019 | $34,301,000 | +55.0% | 2,577,122 | 0.0% | 0.01% | +42.9% |
Q3 2019 | $22,125,000 | -16.8% | 2,577,122 | +6.0% | 0.01% | -12.5% |
Q2 2019 | $26,598,000 | -5.3% | 2,431,240 | +17.1% | 0.01% | -11.1% |
Q1 2019 | $28,092,000 | +43.6% | 2,076,243 | +9.9% | 0.01% | +28.6% |
Q4 2018 | $19,568,000 | -26.5% | 1,888,809 | +31.0% | 0.01% | -22.2% |
Q3 2018 | $26,620,000 | +24.5% | 1,441,994 | +29.0% | 0.01% | +28.6% |
Q2 2018 | $21,373,000 | +38.1% | 1,117,833 | +11.4% | 0.01% | +16.7% |
Q1 2018 | $15,477,000 | -56.1% | 1,003,056 | -57.3% | 0.01% | -53.8% |
Q4 2017 | $35,232,000 | +11.0% | 2,350,397 | +16.7% | 0.01% | +8.3% |
Q3 2017 | $31,751,000 | -23.3% | 2,013,390 | -8.1% | 0.01% | -25.0% |
Q2 2017 | $41,382,000 | +51.2% | 2,191,837 | +36.6% | 0.02% | +45.5% |
Q1 2017 | $27,369,000 | +49.7% | 1,604,304 | +34.2% | 0.01% | +37.5% |
Q4 2016 | $18,285,000 | +13.7% | 1,195,876 | +12.8% | 0.01% | 0.0% |
Q3 2016 | $16,085,000 | +62.6% | 1,060,542 | +40.1% | 0.01% | +60.0% |
Q2 2016 | $9,894,000 | +21.7% | 756,734 | +1.8% | 0.01% | +25.0% |
Q1 2016 | $8,130,000 | -20.8% | 743,134 | -16.1% | 0.00% | -20.0% |
Q4 2015 | $10,266,000 | +27.2% | 885,738 | +14.4% | 0.01% | +25.0% |
Q3 2015 | $8,069,000 | -35.0% | 774,338 | -24.7% | 0.00% | -33.3% |
Q2 2015 | $12,406,000 | -24.6% | 1,028,680 | 0.0% | 0.01% | -25.0% |
Q1 2015 | $16,459,000 | +1186.9% | 1,028,680 | +1132.0% | 0.01% | +700.0% |
Q4 2014 | $1,279,000 | -81.9% | 83,500 | -85.4% | 0.00% | -75.0% |
Q1 2014 | $7,064,000 | -29.3% | 573,338 | -33.4% | 0.00% | -33.3% |
Q4 2013 | $9,991,000 | -2.0% | 860,512 | 0.0% | 0.01% | 0.0% |
Q3 2013 | $10,197,000 | – | 860,512 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
13D Management LLC | 650,455 | $8,371,000 | 2.88% |
BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |